Literature DB >> 20813214

Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders.

Claus Zabel1, Huu Phuc Nguyen, Sascha C Hin, Daniela Hartl, Lei Mao, Joachim Klose.   

Abstract

Neurodegenerative disorders (ND) belong to the most devastating diseases in the industrialized western world. Alzheimer disease (AD) is the most prevalent among these disorders followed by Parkinson disease (PD). Huntington disease (HD) is an autosomal dominantly inherited condition with a single mutation that causes disease in almost 100% of all cases. In this review we used previously published proteomics studies on AD, PD and HD to find cellular pathways changed similarly in ND and aging. All studies employed large gel two dimensional gel electrophoresis for protein separation and mass spectrometry for protein identification. Altered proteins were subjected to a KEGG pathway analysis and altered pathways determined for each disorder and aging. We found that besides the mitochondrial oxidative phosphorylation, the proteasome system are altered in aging and ND. The proteasome facilitates protein degradation which is commonly perturbed in ND which may link neurodegeneration to its largest risk factor-aging.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813214     DOI: 10.1016/j.jprot.2010.08.008

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  13 in total

Review 1.  Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

2.  Inhibition of Mitochondrial Clearance and Cu/Zn-SOD Activity Enhance 6-Hydroxydopamine-Induced Neuronal Apoptosis.

Authors:  Sua In; Chang-Won Hong; Boyoung Choi; Bong-Geum Jang; Min-Ju Kim
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

3.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

4.  RPN-6 determines C. elegans longevity under proteotoxic stress conditions.

Authors:  David Vilchez; Ianessa Morantte; Zheng Liu; Peter M Douglas; Carsten Merkwirth; Ana P C Rodrigues; Gerard Manning; Andrew Dillin
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

5.  The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases.

Authors:  Isabel Saez; David Vilchez
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

Review 6.  Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System.

Authors:  Jonathan Janssens; Harmonie Etienne; Sherif Idriss; Abdelkrim Azmi; Bronwen Martin; Stuart Maudsley
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-01       Impact factor: 5.555

7.  Co-expression network-based analysis of hippocampal expression data associated with Alzheimer's disease using a novel algorithm.

Authors:  Hong Yue; B O Yang; Fang Yang; Xiao-Li Hu; Fan-Bin Kong
Journal:  Exp Ther Med       Date:  2016-03-03       Impact factor: 2.447

Review 8.  Proteostasis of Huntingtin in Health and Disease.

Authors:  Seda Koyuncu; Azra Fatima; Ricardo Gutierrez-Garcia; David Vilchez
Journal:  Int J Mol Sci       Date:  2017-07-19       Impact factor: 5.923

9.  Characterisation of the Mouse Cerebellar Proteome in the GFAP-IL6 Model of Chronic Neuroinflammation.

Authors:  Rustam Asgarov; Monokesh K Sen; Meena Mikhael; Tim Karl; Erika Gyengesi; David A Mahns; Chandra S Malladi; Gerald W Münch
Journal:  Cerebellum       Date:  2021-07-29       Impact factor: 3.847

10.  Enhancing protein disaggregation restores proteasome activity in aged cells.

Authors:  Veronica Andersson; Sarah Hanzén; Beidong Liu; Mikael Molin; Thomas Nyström
Journal:  Aging (Albany NY)       Date:  2013-11       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.